Jonathan Edward Campbell

Jonathan Edward Campbell

Associate Professor in Medicine

Appointments and Affiliations

  • Associate Professor in Medicine
  • Associate Research Professor in Pharmacology & Cancer Biology
  • Member of Duke Molecular Physiology Institute

Contact Information

  • Email Address:


  • Ph.D. York University in Toronto (Canada), 2010

Representative Publications

  • Campbell, JE, Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms., Molecular Metabolism, vol 46 (2021) [10.1016/j.molmet.2020.101139] [abs].
  • El, K; Gray, SM; Capozzi, ME; Knuth, ER; Jin, E; Svendsen, B; Clifford, A; Brown, JL; Encisco, SE; Chazotte, BM; Sloop, KW; Nunez, DJ; Merrins, MJ; D'Alessio, DA; Campbell, JE, GIP mediates the incretin effect and glucose tolerance by dual actions on α cells and β cells., Science Advances, vol 7 no. 11 (2021) [10.1126/sciadv.abf1948] [abs].
  • Huynh, FK; Peterson, BS; Anderson, KA; Lin, Z; Coakley, AJ; Llaguno, FMS; Nguyen, T-TN; Campbell, JE; Stephens, SB; Newgard, CB; Hirschey, MD, β-Cell-specific ablation of sirtuin 4 does not affect nutrient-stimulated insulin secretion in mice., Am J Physiol Endocrinol Metab, vol 319 no. 4 (2020), pp. E805-E813 [10.1152/ajpendo.00170.2020] [abs].
  • Willard, FS; Douros, JD; Gabe, MB; Showalter, AD; Wainscott, DB; Suter, TM; Capozzi, ME; van der Velden, WJ; Stutsman, C; Cardona, GR; Urva, S; Emmerson, PJ; Holst, JJ; D'Alessio, DA; Coghlan, MP; Rosenkilde, MM; Campbell, JE; Sloop, KW, Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist., Jci Insight, vol 5 no. 17 (2020) [10.1172/jci.insight.140532] [abs].
  • Capozzi, ME; Campbell, JE, Could micro changes in β-cells enable major changes in metabolism?, Ebiomedicine, vol 59 (2020) [10.1016/j.ebiom.2020.102936] [abs].